TrialEuropean heart journal2011

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.

Bertram Pitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.